Nano-Oncology

nano-icono

Au-15nm-6The Nano-Oncology line is based on the use of nanotechnology and nano-materials for the development of new nano-systems that enable the diagnosis, evaluation and monitoring of cancer. The aim is to produce technologies and products with clinical applications. To this end, we focus mainly on the synthesis of nano-systems to create nano structures that can improve the current tools used in liquid biopsies.

Dra. Ana Belén Dávila Ibañez is head of the Nano-Oncology line of the Roche-Chus Joint Unit.

Team

ANA
Ana Belén Dávila Ibáñez
Head of the Liquid Nano-Oncology Line of the Roche-Chus Joint Unit
CARMEN
Carmen Abuín Redondo
Laboratory Technician of the Roche-Chus Joint Unit
3
Nuria Carmona Ule
Predoctoral student of the Nano-Oncology line of the Roche-Chus joint Unit
logo-oncomet-def_1
0
Roche_70

La Unidad Mixta Roche-Chus está cofinanciada por la Axencia Galega de Innovación, GAIN de la Xunta de Galicia: “Subvención a organismos de investigación de Galicia para a creación, posta en marcha e impulso de Unidades Mixtas de Investigación” de la Xunta de Galicia en el marco del Plan Galego de Investigación, Innovación e Crecemento- i2C.

logo-gain
c_ceei